Aquestive Therapeutics, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aquestive Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Aquestive Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $159K, a 27.1% decline year-over-year.
  • Aquestive Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $891K, a 18.9% decline year-over-year.
  • Aquestive Therapeutics, Inc. annual Depreciation for 2023 was $1.15M, a 49.2% decline from 2022.
  • Aquestive Therapeutics, Inc. annual Depreciation for 2022 was $2.27M, a 22% decline from 2021.
  • Aquestive Therapeutics, Inc. annual Depreciation for 2021 was $2.91M, a 14.2% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.15M -$1.12M -49.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $2.27M -$642K -22% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $2.91M -$480K -14.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $3.39M +$538K +18.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 $2.85M -$332K -10.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $3.19M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.